CVS to Cover Lilly’s GLP-1 Medications, Expanding Access
CVS Health will broaden coverage for Lilly’s GLP-1 medications, including the new pill Foundayo and Zepbound injectio...
Explore key tips on what not to do when planning for retirement. Avoid common missteps to ensure a successful retirement.
26,407 articlesCVS Health will broaden coverage for Lilly’s GLP-1 medications, including the new pill Foundayo and Zepbound injectio...
ProShares Ultra Silver aimed to double silver's move, but daily resets and volatility trimmed returns, reshaping expe...
AI-driven capex sustains a two-horse race in semiconductors. This piece weighs which is the better semi stock to buy ...
A focused look at the BOSC 2026 earnings transcript for Q1. This article breaks down revenue trends, margin health, a...
As lawmakers push a sweeping crypto regulation bill, the former president's outspoken support for digital assets is c...
Gap's Athleta unit remains a stalemate for the parent company, with a slow recovery in yoga-wear that raises question...
ECB board member Isabel Schnabel presses for a digital euro to counter stablecoin risks, signaling tighter regulation...
Nexa delivered an earnings snapshot that matters for 2026. This guide breaks down the numbers, what they mean for gui...
As KB unveils its Q1 2026 results, investors will parse revenue signals, margin dynamics, and guidance. This guide br...
A rising demand for organ preservation and transplant networks could power meaningful upside in this healthcare infra...
GCOIN makes its WEEX debut as part of a broader plan to list on five exchanges this June, signaling a major push to w...
June opened with volatility as Nu Holdings faced a fresh downgrade and a leadership transition. This article breaks d...